204 results on '"Ou, Wen-Bin"'
Search Results
2. Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer
3. Co-targeting of ACK1 and KIT triggers additive anti-proliferative and -migration effects in imatinib-resistant gastrointestinal stromal tumors
4. Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST
5. Effects of cancer-associated point mutations on the structure, function, and stability of isocitrate dehydrogenase 2
6. Determination of ctDNA, Targeted Therapies and Immunotherapy in Non-small-cell Lung Cancer
7. Recent Study on Therapeutic Targets in Gastrointestinal Stromal Tumors
8. Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
9. Biosynthesis of silver nanoparticles with antimicrobial and anticancer properties using two novel yeasts
10. Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling
11. Supplementary Table S2 from Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma
12. Supplementary Figure S7 from Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma
13. YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways
14. Comparative study on the composition of free amino acids and derivatives in the two botanical origins of an edible Chinese herb “Xiebai”, i.e., Allium chinense G. Don and Allium macrostemon Bunge species
15. Hyper-Dependence on NHEJ Enables Synergy Between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma
16. The hippo pathway provides novel insights into lung cancer and mesothelioma treatment
17. Abstract 3887: ATP-binding pocket substitutions as secondary or tertiary in-cis mutations are major on-target ripretinib resistance mechanisms in gastrointestinal stromal tumor
18. Supplementary Figure Legends from Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors
19. Data from Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors
20. SFigure 1 from Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors
21. SFigure 2 from Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors
22. Human-induced pluripotent stem cell-derived macrophages and their immunological function in response to tuberculosis infection
23. Abstract A013: CDK2 and CDK4/6 inhibition in GIST: Mechanisms of response and resistance
24. Knockdown of creatine kinase B inhibits ovarian cancer progression by decreasing glycolysis
25. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1‐ALK fusions in epithelioid inflammatory myofibroblastic sarcoma
26. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma
27. Abstract 5648: Response and resistance to CDK2 and CDK4/6 inhibition in GIST
28. Aberrant AKT activation drives well-differentiated liposarcoma
29. Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma
30. SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance
31. Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors
32. Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications
33. Proteasome Inhibition Suppresses KIT-Independent Gastrointestinal Stromal Tumors Via Targeting Hippo/YAP/Cyclin D1 Signaling
34. AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression
35. Comparison analysis of Bacillus Calmette-Guerin induced Autophagy mechanisms in Macrophages Derived from Human Induced Pluripotent Stem Cells and THP-1
36. Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer
37. Catalysis of Creatine Kinase Refolding by Protein Disulfide Isomerase Involves Disulfide Cross-link and Dimer to Tetramer Switch
38. Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors
39. Effects of lactic acid and NaCl on creatine kinase from rabbit muscle
40. Conformational changes and inactivation of rabbit muscle creatine kinase in dimethyl sulfoxide solutions
41. Molecular mechanism for osmolyte protection of creatine kinase against guanidine denaturation
42. Folding pathway for partially folded rabbit muscle creatine kinase
43. Effects of arginine on rabbit muscle creatine kinase and salt-induced molten globule-like state
44. Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
45. Co-targeting CK2α and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway
46. Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence
47. WITHDRAWN: Effects of cancer-associated point mutations on the structure, function, and stability of succinate dehydrogenase A
48. Effects of aspartate on rabbit muscle creatine kinase and the salt induced molten globule state
49. Effect of osmolytes as folding aids on creatine kinase refolding pathway
50. Anaplastic lymphoma kinase fusions: Roles in cancer and therapeutic perspectives (Review)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.